Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 5/2009

01-10-2009 | Commentary

The Role of Depression in Predicting Antiretroviral Adherence in Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Commentary on Jayne Byakika-Tusiime et al. 2009

Authors: Etheldreda Nakimuli-Mpungu, Seggane Musisi

Published in: AIDS and Behavior | Issue 5/2009

Login to get access

Excerpt

Sub-Saharan Africa remains the region most heavily affected by HIV, accounting for 67% of all people living with HIV [1]. There remains a need for more comprehensive HIV treatment and prevention programs in this region. In Uganda, ~56% of HIV positive individuals who need treatment have access to anti-retroviral therapy (ART). Activities to scale up provision of ART are taking place country wide with support from Ministry of Health working with various non governmental organizations. The benefits of these efforts critically depend on patients achieving and maintaining high levels of adherence [2]. Therefore, ART programs in Uganda need to ake a holistic approach in addressing all potential barriers to adherence. …
Literature
1.
Joint United Nations Program on HIV/AIDS, World Health Organization. AIDS epidemic update: December 2005. Publication UNAIDS/05.19E. Geneva: UNAIDS; 2005.
2.
Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191(3):339–47.PubMedCrossRef
3.
Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13:S82–91.CrossRef
4.
Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E. Primary mania versus HIV related secondary mania in Uganda. Am J Psychiatry. 2006;163(8):1349–54.PubMedCrossRef
5.
Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S, Katabira E. Early-onset versus late-onset HIV-related secondary mania in Uganda. Psychosomatics. 2008;49(6):530–4.PubMedCrossRef
6.
Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. 2007;68(5):350–5.PubMedCrossRef
7.
Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, et al. The international HIV dementia scale: a new rapid screening test for HIV dementia. AIDS. 2005;19(13):1367–74.PubMed
8.
Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S, Katabira E. The clinical presentation of bipolar disorder mania in HIV positive patients in Uganda (Forth coming in the Psychosomatics 2009 July–Aug issue).
9.
Walters K, Buszewicz M, Russell J, Humphrey C. Teaching as therapy: cross sectional and qualitative evaluation of patients’ experiences of undergraduate psychiatry teaching in the community. BMJ. 2003;326(7392):740.PubMedCrossRef
10.
Beck AT, Steer RA. Internal consistencies of the original and revised Beck depression inventory. J Clin Psychol. 1984;40:1365–7.PubMedCrossRef
11.
Bolton P, Bass J, Neugebauer R, Verdeli H, Clougherty KF, Wickramaratne P, et al. Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. JAMA. 2003;289(23):3117–24.PubMedCrossRef
12.
Wilk CM, Bolton P. Local perceptions of the mental health effects of the Uganda acquired immunodeficiency syndrome epidemic. J Nerv Ment Dis. 2002;190(6):394–7.PubMedCrossRef
13.
Okello ES, Neema S. Explanatory models and help-seeking behavior: pathways to psychiatric care among patients admitted for depression in Mulago hospital, Kampala, Uganda. Qual Health Res. 2007;17(1):14–25.PubMedCrossRef
14.
Okello ES, Ekblad S. Lay concepts of depression among the Baganda of Uganda: a pilot study. Transcult Psychiatry. 2006;43(2):287–313.PubMedCrossRef
15.
Kaharuza FM, Bunnell R, Moss S, Purcell DW, Bikaako-Kajura W, Wamai N, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006;10(Suppl 4):S105–11.PubMedCrossRef
16.
Musisi S, Nakasujja N, Zziwa J. A comparison of depression among patients with HIV/AIDS and pulmonary tuberculosis. Proceedings of the African Association of Psychiatry and Allied Professions Annual Conference. Nairobi, Kenya; March 21–23, 2007.
17.
Akena DH, Musisi S, Kinyanda E. A comparative study of depression among HIV positive and HIV-negative patients in Butabika and Mulago hospitals, Uganda. Procedings for the 4th Annual Makerere University College of Health Sciences Scientific conference 17–19 September 2008.
18.
Nakasujja N, Skolasky RL, Musisi S, Allebeck P, Robertson K, Ronald A, Katabira E, Clifford DB, Sacktor N. Depression symptoms and cognitive function among HIV positive individuals in Uganda. Proceedings for the 4th Annual Makerere University College of Health Sciences Scientific conference 17–19 September 2008.
19.
Schulberg HC, Katon WJ, Simon GE, Rush AJ. Best clinical practice: guidelines for managing major depression in primary medical care. J Clin Psychiatry. 1999;60(Suppl 7):19–26. (discussion 27-8).PubMed
20.
Gibbie T, Hay M, Hutchison CW, Mijch A. Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS. Sex Health. 2007;4(4):227–32.PubMedCrossRef
21.
Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–90.PubMedCrossRef
22.
Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry. 2001;3(6):244–54.PubMedCrossRef
23.
Hasin DS, Glick H. Depressive symptoms and DSM-III-R alcohol dependence: general population results. Addiction. 1993;88(10):1431–6.PubMedCrossRef
24.
Jacobs N, Rijsdijk F, Derom C, Vlietinck R, Delespaul P, van Os J, et al. Genes making one feel blue in the flow of daily life: a momentary assessment study of gene stress interaction. Psychosom Med. 2006;68(2):201–6.PubMedCrossRef
Metadata
Title
The Role of Depression in Predicting Antiretroviral Adherence in Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Commentary on Jayne Byakika-Tusiime et al. 2009
Authors
Etheldreda Nakimuli-Mpungu
Seggane Musisi
Publication date
01-10-2009
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9600-8

Other articles of this Issue 5/2009

AIDS and Behavior 5/2009 Go to the issue

Original Paper

Correlation Between HIV and Sexual Behavior, Drug Use, Trichomoniasis and Candidiasis Among Female Sex Workers in a Mekong Delta Province of Vietnam

Original Paper

Negative Mental Health Factors in Children Orphaned by AIDS: Natural Mentoring as a Palliative Care

Original Paper

Sexual Behavior of Female Sex Workers and Access to Condoms in Kenya and Uganda on the trans-Africa Highway

Original Paper

Clients of Female Sex Workers as a Bridging Population in Vietnam

Original Paper

Family Planning Among HIV Positive and Negative Prevention of Mother to Child Transmission (PMTCT) Clients in a Resource Poor Setting in South Africa

Original Paper

A Systematic Review of Factors Influencing Fertility Desires and Intentions Among People Living with HIV/AIDS: Implications for Policy and Service Delivery
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits